Daniel Korr

Daniel Korr is currently the Head of Therapeutic Compound Research Laboratory at NUVISAN The Science CRO. Prior to this, Daniel held various positions at Bayer, including as Head of Oncology Research Laboratory. Daniel has a Ph.D. in Biochemistry from Schering AG and has a strong background in oncology research.